Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH) (XABG-FIH)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04545112 |
Recruitment Status :
Enrolling by invitation
First Posted : September 10, 2020
Last Update Posted : January 26, 2023
|
Sponsor:
Xeltis
Information provided by (Responsible Party):
Xeltis
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Enrolling by invitation |
---|---|
Estimated Primary Completion Date : | March 15, 2026 |
Estimated Study Completion Date : | March 15, 2026 |